Bioniz Therapeutics
Jan 09, 2020
Novome raises USD 33M, Buyout of Bioniz, Adagene raises USD 69M
A biotech company Novome Biotechnologies is developing novel live medicines for chronic diseases, has raised USD 33 Million in Series A financing. The financing was led by DCVC Bio with participation from seed investor 5AM Ventures, Alta Partners, Alexandria Venture Investments and Mayo Clinic. The company plan...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
